loadpatents
name:-0.024306058883667
name:-0.013059854507446
name:-0.0060880184173584
Subramanian; Ilango Patent Filings

Subramanian; Ilango

Patent Applications and Registrations

Patent applications and USPTO patent grants for Subramanian; Ilango.The latest application filed is for "limited particle size triamcinolone and moxifloxacin compositions and associated methods of use".

Company Profile
5.12.31
  • Subramanian; Ilango - Warren NJ
  • Subramanian; Ilango - Somerset NJ
  • Subramanian; Ilango - Mendham NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of use
Grant 11,446,242 - Shah , et al. September 20, 2
2022-09-20
Moxifloxacin and triamcinolone compositions and associated methods
Grant 11,439,591 - Shah , et al. September 13, 2
2022-09-13
Glycopeptide antibiotics liquid formulations and methods and uses thereof
Grant 11,433,115 - Shah , et al. September 6, 2
2022-09-06
Preparation of microparticulate methylprednisolone acetate suspension
Grant 11,433,084 - Kalhapure , et al. September 6, 2
2022-09-06
Effective benzalkonium chloride-free bimatoprost ophthalmic compositions
Grant 11,400,100 - Shah , et al. August 2, 2
2022-08-02
Liquid ready-to-use formulation of levothyroxine
Grant 11,400,068 - Akasapu , et al. August 2, 2
2022-08-02
Combination products of tobramycin compounds and dexameihasone compounds
Grant 11,395,831 - Shah , et al. July 26, 2
2022-07-26
Loteprednol and moxifloxacin compositions and methods
Grant 11,382,910 - Shah , et al. July 12, 2
2022-07-12
Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid
Grant 11,382,863 - Kalhapure , et al. July 12, 2
2022-07-12
Moxifloxacin And Triamcinolone Compositions And Associated Methods
App 20220183966 - Shah; Mandar V. ;   et al.
2022-06-16
Limited Particle Size Triamcinolone And Moxifloxacin Compositions And Associated Methods Of Use
App 20220183967 - Shah; Mandar V. ;   et al.
2022-06-16
Suspension Component-specific Triamcinolone And Moxifloxacin Compositions And Associated Methods Of Use
App 20220183968 - Shah; Mandar V. ;   et al.
2022-06-16
Tobramycin compound conjugates and derivative compositions
Grant 11,344,566 - Shah , et al. May 31, 2
2022-05-31
Glycopeptide Antibiotics Liquid Formulations And Methods And Uses Thereof
App 20220133845 - SHAH; Mandar V. ;   et al.
2022-05-05
Glycopeptide Antibiotics Liquid Formulations And Methods And Uses Thereof
App 20220133844 - SHAH; Mandar V. ;   et al.
2022-05-05
Triamcinolone and moxifloxacin compositions
Grant 11,298,315 - Shah , et al. April 12, 2
2022-04-12
Efficient tobramycin compound conjugate compositions
Grant 11,298,368 - Shah , et al. April 12, 2
2022-04-12
Efficient Brinzolamide And Brimonidine Compositions
App 20220105101 - Shah; Mandar V. ;   et al.
2022-04-07
Safe Brinzolamide And Brimonidine Compositions With Enhanced Benzalkonium Chloride Content
App 20220105100 - Shah; Mandar V. ;   et al.
2022-04-07
Methods Of Efficiently Reducing Intraocular Pressure
App 20220105102 - Shah; Mandar V. ;   et al.
2022-04-07
Safe Use Of Brinzolamide And Brimonidine Compositions With Enhanced Benzalkonium Chloride Content
App 20220105103 - Shah; Mandar V. ;   et al.
2022-04-07
Gatifloxacin, Prednisolone, And Bromfenac Compositions And Methods
App 20220062302 - Shah; Mandar V. ;   et al.
2022-03-03
Loteprednol And Moxifloxacin Compositions And Methods
App 20220062271 - Shah; Mandar V. ;   et al.
2022-03-03
Trimcinolone And Moxifloxacin Methods
App 20220062168 - Shah; Mandar V. ;   et al.
2022-03-03
Bromfenac, Prednisolone, And Moxifloxacin Compositions And Methods
App 20220062301 - Shah; Mandar V. ;   et al.
2022-03-03
Triamcinolone And Moxifloxacin Compositions
App 20220062167 - Shah; Mandar V. ;   et al.
2022-03-03
Prednisolone And Moxifloxacin Compositions And Methods
App 20220062303 - Shah; Mandar V. ;   et al.
2022-03-03
Efficient Tobramycin Compound Conjugate Compositions
App 20220054519 - Shah; Mandar V. ;   et al.
2022-02-24
Tobramycin Compound-copolymer Conjugates And Derivative Compositions
App 20220054517 - Shah; Mandar V. ;   et al.
2022-02-24
Tobramycin Compound Conjugate Formulations
App 20220054518 - Shah; Mandar V. ;   et al.
2022-02-24
Epinephrine Parenteral Formulations
App 20220016054 - Shah; Mandar V. ;   et al.
2022-01-20
Liquid Ready-to-use Formulation Of Levothyroxine
App 20210386699 - Akasapu; Prem Sagar ;   et al.
2021-12-16
Combination Products Of Tobramycin Compounds And Dexamethasone Compounds
App 20210361687 - Shah; Mandar V. ;   et al.
2021-11-25
Tobramycin Compound Conjugates And Derivative Compositions
App 20210361685 - Shah; Mandar V. ;   et al.
2021-11-25
Methods Of Treating Eye Disease With Tobramycin-related Compositions
App 20210361686 - Shah; Mandar V. ;   et al.
2021-11-25
Cetirizine Ophthalmic Compositions
App 20210299121 - Shah; Mandar V. ;   et al.
2021-09-30
Injectable Suspension Comprising An Insoluble Corticosteroid And A Soluble Corticosteroid
App 20210275451 - Kalhapure; Rahul ;   et al.
2021-09-09
Preparation of Microparticulate Triamcinolone Acetonide Injectable Suspension
App 20210251903 - Kalhapure; Rahul ;   et al.
2021-08-19
Preparation of Microparticulate Methylprednisolone Acetate Suspension
App 20210252019 - Kalhapure; Rahul ;   et al.
2021-08-19
Aprepitant ready-to-use injection emulsion compositions
App 20210212933 - Akasapu; Prem Sagar ;   et al.
2021-07-15
Low Benzalkonium Chloride Bimatoprost Ophthalmic Compositions With Effective Penetration & Preservation Properties
App 20210205327 - Shah; Mandar V. ;   et al.
2021-07-08
Effective Benzalkonium Chloride-free Bimatoprost Ophthalmic Compositions
App 20210177780 - Shah; Mandar V ;   et al.
2021-06-17
Low Benzalkonium Chloride Bimatoprost Ophthalmic Compositions With Effective Penetration & Preservation Properties
App 20210177863 - Shah; Mandar V. ;   et al.
2021-06-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed